Steadvar — News without the noise

Privacy · Terms · About

© 2026 Steadvar. All rights reserved.

Brain Circuit Discovery Could Offer New Path to Treat Chronic Pain

HealthScience4/27/2026
Share

Similar Articles

Study Reveals Brain Moves with Body Movement, Possibly Aiding Waste Clearance

ScienceHealth5/1/2026

New Study Identifies Distinct Brain Cell Changes in Depression

HealthScience4/23/2026

Researchers Identify Brain Cell Process That Removes Alzheimer's Plaques in Mice

ScienceHealth5/2/2026

New Imaging Technique Reveals Immune Cell Killing Machinery

ScienceHealth4/30/2026

Study Finds Body Processes Facial Itches Differently Than Body Itches

ScienceHealth14h ago

Researchers have identified a specific brain circuit that appears to determine whether short-term pain becomes chronic. In animal studies, shutting down this circuit prevented chronic pain from developing and stopped it after it had already begun. This finding could lead to new treatments for the one in four adults who experience chronic pain.

Facts First

  • A brain circuit in the caudal granular insular cortex (CGIC) may control the transition to chronic pain.
  • Deactivating the CGIC circuit in animals prevented chronic pain and stopped existing pain.
  • The CGIC is a small region deep in the brain that sends signals to the spinal cord to maintain pain.
  • The circuit is not essential for immediate pain but is essential for maintaining pain over time.
  • Approximately one in four adults experiences chronic pain, according to the CDC.

What Happened

Researchers from the University of Colorado Boulder identified a brain circuit in the caudal granular insular cortex (CGIC) that may determine if short-term pain becomes chronic pain. The study, published in the Journal of Neuroscience, was conducted in animals. The CGIC is a small region, approximately the size of a sugar cube, located deep within the insula of the brain.

In the study, researchers used fluorescent proteins to track nerve cell activity in rats following a sciatic nerve injury. They utilized 'chemogenetic' methods to activate or deactivate specific genes within selected neurons. The CGIC sends signals to the somatosensory cortex, which then communicates with the spinal cord to instruct it to continue transmitting pain signals.

Why this Matters to You

Chronic pain is a widespread condition; according to the Centers for Disease Control (CDC), approximately one in four adults experiences it, and nearly one in 10 report that it interferes with their daily lives. This research could lead to new, targeted treatments that work differently from current painkillers. If future therapies based on this circuit prove effective, you or someone you know might have access to a treatment that directly interrupts the brain's mechanism for sustaining pain, potentially offering relief where other options have failed.

What's Next

This discovery, while promising, is based on animal studies. The next steps will likely involve further research to confirm these mechanisms and explore how to safely target the CGIC circuit in humans. Studies in humans have already shown that the CGIC area tends to be overactive in individuals with chronic pain, which supports the potential relevance of this finding. The research may eventually inform the development of new drugs or neuromodulation devices designed to quiet this specific brain pathway and provide lasting relief from chronic pain.

Perspectives

“
Lead Researchers assert that the study identifies a specific brain circuit responsible for chronic pain and suggests that silencing this "crucial decision maker" can cause chronic pain to "melt away".
“
Neuroscience Experts characterize the current period as a "gold rush of neuroscience" and argue that advanced tools allow for the precise manipulation of cell populations to accelerate the development of new treatments.
“
Medical Visionaries envision a future where targeted brain cell modulation via injections or brain-machine interfaces provides a way to manage severe pain while avoiding the "side effects and addiction risks of opioids".